• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用计算机模拟方法研究取代基对 PAK4 抑制作用的影响。

A Study on the Effect of the Substituent against PAK4 Inhibition Using In Silico Methods.

机构信息

Graduate School of New Drug Discovery and Development, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Korea.

Pharos iBio Co., Ltd. #1408, 38 Heungan-daero 427, Dongan-gu, Anyang-si 14059, Korea.

出版信息

Int J Mol Sci. 2022 Mar 19;23(6):3337. doi: 10.3390/ijms23063337.

DOI:10.3390/ijms23063337
PMID:35328758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8953563/
Abstract

The intrinsic inductive properties of atoms or functional groups depend on the chemical properties of either electron-withdrawing groups (EWGs) or electron-donating groups (EDGs). This study aimed to evaluate in silico methods to determine whether changes in chemical properties of the compound by single atomic substitution affect the biological activity of target proteins and whether the results depend on the properties of the functional groups. We found an imidazo[4,5-b]pyridine-based PAK4 inhibitor, compound , as an initial hit compound with the well-defined binding mode for PAK4. In this study, we used both experimental and in silico methods to investigate the effect of atomic substitution on biological activity to optimize the initial hit compound. In biological assays, in the case of EWG, as the size of the halogen atom became smaller and the electronegativity increased, the biological activity IC value ranged from 5150 nM to inactive; in the case of EDG, biological activity was inactive. Furthermore, we analyzed the interactions of PAK4 with compounds, focusing on the hinge region residues, L398 and E399, and gatekeeper residues, M395 and K350, of the PAK4 protein using molecular docking studies and fragment molecular orbital (FMO) methods to determine the differences between the effect of EWG and EDG on the activity of target proteins. These results of the docking score and binding energy did not explain the differences in biological activity. However, the pair-interaction energy obtained from the results of the FMO method indicated that there was a difference in the interaction energy between the EWG and EDG in the hinge region residues, L398 and E399, as well as in M395 and K350. The two groups with different properties exhibited opposite electrostatic energy and charge transfer energy between L398 and E399. Additionally, we investigated the electron distribution of the parts interacting with the hinge region by visualizing the molecular electrostatic potential (MEP) surface of the compounds. In conclusion, we described the properties of functional groups that affect biological activity using an in silico method, FMO.

摘要

原子或官能团的固有感应性质取决于吸电子基团 (EWG) 或供电子基团 (EDG) 的化学性质。本研究旨在评估计算方法,以确定化合物的化学性质通过单个原子取代而发生变化是否会影响靶蛋白的生物活性,以及结果是否取决于官能团的性质。我们发现一种基于咪唑并[4,5-b]吡啶的 PAK4 抑制剂,化合物 ,作为具有明确 PAK4 结合模式的初始命中化合物。在这项研究中,我们使用实验和计算方法来研究原子取代对生物活性的影响,以优化初始命中化合物。在生物测定中,对于 EWG,随着卤原子的尺寸变小和电负性增加,生物活性 IC 值范围为 5150 nM 至无活性;对于 EDG,生物活性无活性。此外,我们使用分子对接研究和片段分子轨道 (FMO) 方法分析了 PAK4 与化合物的相互作用,重点是 PAK4 蛋白的 hinge 区域残基 L398 和 E399 以及 gatekeeper 残基 M395 和 K350,以确定 EWG 和 EDG 对靶蛋白活性的影响之间的差异。对接得分和结合能的这些结果并不能解释生物活性的差异。然而,从 FMO 方法的结果中获得的偶极子相互作用能表明,在 hinge 区域残基 L398 和 E399 以及 M395 和 K350 中,EWG 和 EDG 之间的相互作用能存在差异。这两组具有不同性质的基团在 L398 和 E399 之间表现出相反的静电能和电荷转移能。此外,我们通过可视化化合物的分子静电势 (MEP) 表面研究了与 hinge 区域相互作用的部分的电子分布。总之,我们使用计算方法 FMO 描述了影响生物活性的官能团的性质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e575/8953563/a5d7cf0b0d33/ijms-23-03337-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e575/8953563/b2a536f02155/ijms-23-03337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e575/8953563/939ba0a324b9/ijms-23-03337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e575/8953563/d00f5c582105/ijms-23-03337-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e575/8953563/1444e16f0910/ijms-23-03337-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e575/8953563/797b95400d75/ijms-23-03337-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e575/8953563/a5d7cf0b0d33/ijms-23-03337-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e575/8953563/b2a536f02155/ijms-23-03337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e575/8953563/939ba0a324b9/ijms-23-03337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e575/8953563/d00f5c582105/ijms-23-03337-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e575/8953563/1444e16f0910/ijms-23-03337-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e575/8953563/797b95400d75/ijms-23-03337-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e575/8953563/a5d7cf0b0d33/ijms-23-03337-g006.jpg

相似文献

1
A Study on the Effect of the Substituent against PAK4 Inhibition Using In Silico Methods.使用计算机模拟方法研究取代基对 PAK4 抑制作用的影响。
Int J Mol Sci. 2022 Mar 19;23(6):3337. doi: 10.3390/ijms23063337.
2
Discovery of 2,4-diaminopyrimidine derivatives targeting p21-activated kinase 4: Biological evaluation and docking studies.靶向 p21 激活激酶 4 的 2,4-二氨基嘧啶衍生物的发现:生物学评价和对接研究。
Arch Pharm (Weinheim). 2020 Oct;353(10):e2000097. doi: 10.1002/ardp.202000097. Epub 2020 Jul 6.
3
Kaempferol as a Potential PAK4 Inhibitor in Triple Negative Breast Cancer: Extra Precision Glide Docking and Free Energy Calculation.山奈酚作为三阴性乳腺癌潜在的 PAK4 抑制剂:额外精准 Glide 对接和自由能计算。
Curr Drug Discov Technol. 2020;17(5):682-695. doi: 10.2174/1570163816666190823135948.
4
In silico studies on p21-activated kinase 4 inhibitors: comprehensive application of 3D-QSAR analysis, molecular docking, molecular dynamics simulations, and MM-GBSA calculation.基于结构的 p21 激活激酶 4 抑制剂虚拟筛选研究:3D-QSAR 分析、分子对接、分子动力学模拟和 MM-GBSA 计算的综合应用。
J Biomol Struct Dyn. 2020 Sep;38(14):4119-4133. doi: 10.1080/07391102.2019.1673823. Epub 2019 Oct 11.
5
The Inhibitory Mechanism of 7-Pyrrolo[2,3-d]pyrimidine Derivatives as Inhibitors of P21-Activated Kinase 4 through Molecular Dynamics Simulation.7-吡咯并[2,3-d]嘧啶衍生物作为 P21 激活激酶 4 抑制剂的抑制机制:分子动力学模拟。
Molecules. 2023 Jan 3;28(1):413. doi: 10.3390/molecules28010413.
6
Discovery of indolin-2-one derivatives as potent PAK4 inhibitors: Structure-activity relationship analysis, biological evaluation and molecular docking study.吲哚-2-酮衍生物作为强效PAK4抑制剂的发现:构效关系分析、生物学评价及分子对接研究
Bioorg Med Chem. 2017 Jul 1;25(13):3500-3511. doi: 10.1016/j.bmc.2017.04.047. Epub 2017 May 3.
7
Development of 2, 4-diaminoquinazoline derivatives as potent PAK4 inhibitors by the core refinement strategy.通过核心优化策略开发2,4-二氨基喹唑啉衍生物作为有效的PAK4抑制剂。
Eur J Med Chem. 2017 May 5;131:1-13. doi: 10.1016/j.ejmech.2017.02.063. Epub 2017 Mar 8.
8
The discovery and the structural basis of an imidazo[4,5-b]pyridine-based p21-activated kinase 4 inhibitor.一种基于咪唑并[4,5-b]吡啶的p21激活激酶4抑制剂的发现及其结构基础。
Bioorg Med Chem Lett. 2016 Jun 1;26(11):2580-3. doi: 10.1016/j.bmcl.2016.04.037. Epub 2016 Apr 16.
9
Molecular dynamics simulation and QM/MM calculation reveal the selectivity mechanism of type I 1/2 kinase inhibitors: the effect of intramolecular H-bonds and conformational restriction for improved selectivity.分子动力学模拟和量子力学/分子力学计算揭示了 I 型 1/2 激酶抑制剂的选择性机制:分子内氢键和构象限制的影响可提高选择性。
Phys Chem Chem Phys. 2019 Nov 7;21(43):24147-24164. doi: 10.1039/c9cp04353e.
10
Precise design of highly isoform-selective p21-activated kinase 4 inhibitors: computational insights into the selectivity mechanism through molecular dynamics simulation and binding free energy calculation.高度同工型选择性 p21 激活激酶 4 抑制剂的精确设计:通过分子动力学模拟和结合自由能计算深入了解选择性机制的计算见解。
J Biomol Struct Dyn. 2020 Aug;38(13):3825-3837. doi: 10.1080/07391102.2019.1664330. Epub 2019 Sep 15.

引用本文的文献

1
Affinity Purification and Molecular Characterization of Angiotensin-Converting Enzyme (ACE)-Inhibitory Peptides from .从 中亲和纯化和分子鉴定血管紧张素转化酶(ACE)抑制肽。
Mar Drugs. 2023 Sep 29;21(10):522. doi: 10.3390/md21100522.
2
Synthesis, anti-amoebic activity and molecular docking simulation of eugenol derivatives against sp.丁香酚衍生物对特定物种的合成、抗阿米巴活性及分子对接模拟
Saudi Pharm J. 2023 Sep;31(9):101703. doi: 10.1016/j.jsps.2023.101703. Epub 2023 Jul 18.
3
Targeting TLR2/Rac1/cdc42/JNK Pathway to Reveal That Ruxolitinib Promotes Thrombocytopoiesis.

本文引用的文献

1
Enhancing Sampling of Water Rehydration on Ligand Binding: A Comparison of Techniques.增强配体结合时水合作用的采样:技术比较
J Chem Theory Comput. 2022 Mar 8;18(3):1359-1381. doi: 10.1021/acs.jctc.1c00590. Epub 2022 Feb 11.
2
Why is PAK4 overexpressed in cancer?PAK4 为什么在癌症中过表达?
Int J Biochem Cell Biol. 2021 Sep;138:106041. doi: 10.1016/j.biocel.2021.106041. Epub 2021 Jul 15.
3
CDK15 promotes colorectal cancer progression via phosphorylating PAK4 and regulating β-catenin/ MEK-ERK signaling pathway.
靶向 TLR2/Rac1/cdc42/JNK 通路揭示芦可替尼促进血小板生成。
Int J Mol Sci. 2022 Dec 17;23(24):16137. doi: 10.3390/ijms232416137.
CDK15 通过磷酸化 PAK4 和调控 β-catenin/MEK-ERK 信号通路促进结直肠癌进展。
Cell Death Differ. 2022 Jan;29(1):14-27. doi: 10.1038/s41418-021-00828-6. Epub 2021 Jul 14.
4
Gastric Cancer: Identification of microRNAs Inhibiting Druggable Targets and Mediating Efficacy in Preclinical Models.胃癌:鉴定抑制可成药靶点的 microRNAs 和介导临床前模型疗效的 microRNAs。
Cancer Genomics Proteomics. 2021 Jul-Aug;18(4):497-514. doi: 10.21873/cgp.20275.
5
FMODB: The World's First Database of Quantum Mechanical Calculations for Biomacromolecules Based on the Fragment Molecular Orbital Method.FMODB:世界上第一个基于片段分子轨道方法的生物大分子量子力学计算数据库。
J Chem Inf Model. 2021 Feb 22;61(2):777-794. doi: 10.1021/acs.jcim.0c01062. Epub 2021 Jan 29.
6
Computational mechanistic study of the unimolecular dissociation of ethyl hydroperoxide and its bimolecular reactions with atmospheric species.乙基过氧化物的单分子离解及其与大气物种的双分子反应的计算力学研究。
Sci Rep. 2020 Sep 14;10(1):15025. doi: 10.1038/s41598-020-71881-3.
7
Discovery of 2,4-diaminopyrimidine derivatives targeting p21-activated kinase 4: Biological evaluation and docking studies.靶向 p21 激活激酶 4 的 2,4-二氨基嘧啶衍生物的发现:生物学评价和对接研究。
Arch Pharm (Weinheim). 2020 Oct;353(10):e2000097. doi: 10.1002/ardp.202000097. Epub 2020 Jul 6.
8
Multiscale Molecular Modeling in G Protein-Coupled Receptor (GPCR)-Ligand Studies.多尺度分子建模在 G 蛋白偶联受体(GPCR)-配体研究中的应用。
Biomolecules. 2020 Apr 19;10(4):631. doi: 10.3390/biom10040631.
9
New control of the senescence barrier in breast cancer.乳腺癌衰老屏障的新调控
Mol Cell Oncol. 2020 Jan 20;7(2):1684129. doi: 10.1080/23723556.2019.1684129. eCollection 2020.
10
Guiding Medicinal Chemistry with Fragment Molecular Orbital (FMO) Method.基于片段分子轨道(FMO)方法的药物化学指导。
Methods Mol Biol. 2020;2114:37-48. doi: 10.1007/978-1-0716-0282-9_3.